MannKind Corp. (MNKD)
5.94
+0.13
(+2.24%)
USD |
NASDAQ |
Dec 12, 11:15
MannKind Research and Development Expense (Quarterly): 14.06M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 977.70M |
| Ocugen, Inc. | 10.20M |
| Protagonist Therapeutics, Inc. | 40.00M |
| Ovid Therapeutics, Inc. | 5.853M |
| Moderna, Inc. | 749.00M |